Das Gesundheitswesen , Thieme Verlag Heft 8/9-2021, Jahrgang 83) ISSN 1439-4421 Seite(n) e41 bis e48 DOI: 10.1055/a-1531-5507 CareLit-Dokument-Nr: 318600 |
|
ABSTRACT Objective Well-established mortality ratio methodology can contribute to a fuller picture of the SARS-CoV-2/COVID-19 burden of disease by revealing trends and informing mitigation strategies. This work examines respective data from Germany by way of example. Methods Using monthly and weekly all-cause mortality data from January 2016 to June 2020 (published by the German Federal Statistical Institute) for all ages,<65 years and≥65 years, and specified for Germany’s federal states, we explored mortality as sequela of COVID-19. We analysed standardized mortality ratios (SMRs) comparing 2020 with 2016–2019 as reference years with a focus on trend detection. Results In Germany as a whole, elevated mortality in April (most pronounced for Bavaria) declined in May. The states of Hamburg and Bremen had increased SMRs in all months under study. In Mecklenburg-Western Pomerania, decreased SMRs in January turned monotonically to increased SMRs by June. Irrespective of age group, this trend was pronounced and significant. Conclusions Increased SMRs in Hamburg and Bremen must be interpreted with caution because of potential upward distortions due to a “catchment bias”. A pronounced excess mortality in April across Germany was confirmed and a hitherto undetected trend of increasing SMRs for Mecklenburg-Western Pomerania was revealed. To meet the pandemic challenge and to benefit from research based on data collected in standardized ways, national authorities should regularly conduct SMR analyses. For independent analyses, national authorities should also expedite publishing raw mortality and population data, including detailed information on age, sex, and cause of death, in the public domain. Key words SARS-CoV-2/COVID-19 - SMR - excess mortality - epidemiology - surveillance 08 September 2021 © 2021. Thieme. All rights reserved. Georg Thieme Verlag Rüdigerstraße 14, 70469 Stuttgart, Germany References 1 Callaway E, Cyranoski D. China coronavirus: Six questions scientists are asking. Nature 2020; 577: 605-607 CrossrefPubMedGoogle Scholar 2 Odone A. et al. The first 10,000 COVID-19 papers in perspective: Are we publishing what we should be publishing?. Eur J Public Health 2020; 30: 849-850 CrossrefPubMedGoogle Scholar 3 Leon DA. et al. COVID-19: a need for real-time monitoring of weekly excess deaths. Lancet 2020; 395: e81 CrossrefPubMedGoogle Scholar 4 Morfeld P. et al. COVID-19: Spatial resolution of excess mortality in Germany and Italy. J Infect 2021; 27: e12630 PubMedGoogle Scholar 5 Morfeld P, Erren TC. Deaths in nine regions of Italy in February/March 2020: “Mortality Excess Loupe” for SARS-CoV-2/COVID-19-Epidemiology in Germany. Gesundheitswesen 2020; 82: 400-406 Article in Thieme ConnectPubMedGoogle Scholar 6 Morfeld P, Erren TC. Mortality and Attributable Fraction in COVID-19 Analysis: Avoiding Research Waste and Negligence. Am J Public Health 2020; 110: 1644-1645 CrossrefPubMedGoogle Scholar 7 Destatis. Sterbefälle - Fallzahlen nach Tagen, Wochen, Monaten, Altersgruppen und Bundesländern für Deutschland 2016–2020. 2020 23.6.2020]; Available from: https://www.destatis.de/DE/Themen/Gesellschaft-Umwelt/Bevoelkerung/Sterbefaelle-Lebenserwartung/Tabellen/sonderauswertung-sterbefaelle.html 8 Breslow NE, Day NE. Statistical methods in cancer research. Volume II – The design and analysis of cohort studies. Lyon: International Agency for Research on Cancer; 1987 CrossrefGoogle Scholar 9 Rothman KJ, Greenland S, Lash TL. Modern epidemiology. 3rd ed. 2008. Philadelphia: Lippincott Williams & Wilkins; Google Scholar 10 Checkoway H, Pearce N, Kriebel D. Research methods in occupational epidemiology. vol. 34, 2nd ed. 2004. New York: Oxford University Press; CrossrefGoogle Scholar 11 Armitage P, Berry G. Statistical Methods in Medical Research. 1988. Blackwell Scientific Publications; Oxford: 2nd Edition Google Scholar 12 Sutton AJ, Abrams KR, Jones DR. et al. Methods for Meta-analysis in Medical Research. 2000. Wiley; Chichester, U.K: Google Scholar 13 Nielsen J. et al. Pooling European all-cause mortality: methodology and findings for the seasons 2008/2009 to 2010/2011. Epidemiol Infect 2013; 141: 1996-2010 CrossrefPubMedGoogle Scholar 14 Cameron AC, Trivedi PK. Microeconometrics. Methods and Applications. 2005. New York: Cambridge University Press; CrossrefGoogle Scholar 15 Cameron AC, Trivedi PK. Microeconometrics using Stata. 2010. A Stata Press Publication, Stata Corp LP; College Station, Texas: Revised Edition Google Scholar 16 Stang A. et al. Excess mortality due to COVID-19 in Germany. J Infect 2020; 81: 797-801 CrossrefPubMedGoogle Scholar 17 Morfeld P, Timmermann B, Groß JV. et al. COVID-19: Spatial resolution of excess mortality in Germany and Italy. Journal of Infection 2021; 82: 421-422 CrossrefPubMedGoogle Scholar 18 Morfeld P, Timmermann B, Groß JV. et al. COVID-19: Wie änderte sich die Sterblichkeit? – Mortalität von Frauen und Männern in Deutschland und seinen Bundesländern bis Oktober 2020 [COVID-19: How did mortality change?. Mortality of women and men in Germany and its federal states until October 2020] Dtsch Med Wochenschr 2021; 146: 129-131 PubMedGoogle Scholar 19 Morfeld P, Timmermann B, Gross JV. et al. COVID-19: Mortality in Germany 2020 - Reply to the Letter. Dtsch Med Wochenschr 146: 427 DOI: 10.1055/a-1385-7759. 2021; Article in Thieme ConnectPubMedGoogle Scholar 20 Morfeld P, Timmermann B, Groß JV. et al. COVID-19: Heterogeneous excess mortality and “burden of disease” in Germany and Italy and their states and regions, January – June 2020. Frontiers in Public Health, section Infectious Diseases – Surveillance, Prevention and Treatment. 2021 DOI: 10.3389/fpubh.2021.663259 Google Scholar 21 zur Nieden F, Sommer B, Lüken S. Sonderauswertung der Sterbefallzahlen 2020 - Daten zur Einordnung einer zeitweisen Übersterblichkeit im Zusammenhang mit der Corona-Pandemie. Statistisches Bundesamt | WISTA | 4 |. 2020 Google Scholar 22 Vestergaard LS. et al. Excess all-cause mortality during the COVID-19 pandemic in Europe – preliminary pooled estimates from the EuroMOMO network, March to April 2020. Euro Surveill. 2020 25. Google Scholar 23 Erren TC, Morfeld P. COVID-19-Mortalität: Mit viel Sicht fliegen. Dtsch Ärztebl 2020; 117: A-1010 /B-850 PubMedGoogle Scholar 24 Laufs J. et al. Coronavirus (SARS-CoV-2) – Outbreak in North Rhine-Westphalia (District of Heinsberg) – First diagnosis of a COVID-19 manifestation in a couple. Dtsch Med Wochenschr 2020; 145: 665-669 Article in Thieme ConnectPubMedGoogle Scholar 25 (Destatis), S.B. Genesis Database. 2020 24.07.2020/07:17]; Available from https://www-genesis.destatis.de/genesis//online?operation=table&code=12411-0013&bypass=true&levelindex=0&levelid=1598588177483#abreadcrumb 26 Hammitt JK. et al. Premature Deaths, Statistical Lives, and Years of Life Lost: Identification, Quantification, and Valuation of Mortality Risks. Risk Anal 2020; 40: 674-695 CrossrefPubMedGoogle Scholar 27 Küpke NK. et al. Gesetz für den Schutz vor Masern und zur Stärkung der Impfprävention (Masernschutzgesetz). Epid Bull 2020; 10: 3-5 Google Scholar 28 network E. Available from https://www.euromomo.eu/ 29 Lewis P, Erren TC. COVID-19: science must not be the boy who cried wolf. J Epidemiol Community Health 2020; 74: 676 PubMedGoogle Scholar 30 Yelin D. et al. Long-term consequences of COVID-19: research needs. Lancet Infect Dis 2020; 20: 1115-1117 CrossrefPubMedGoogle Scholar 31 Rubino F. et al. New-Onset Diabetes in Covid-19. N Engl J Med 2020; 383: 789-790 CrossrefPubMedGoogle Scholar 32 Setti L. et al. Increased incidence of interstitial pneumonia detected on [(18)F]-FDG-PET/CT in asymptomatic cancer patients during COVID-19 pandemic in Lombardy: a casualty or COVID-19 infection? Eur J Nucl Med Mol Imaging. 2020 Google Scholar 33 Schwartz DA et al. Confirming Vertical Fetal Infection with COVID-19: Neonatal and Pathology Criteria for Early Onset and Transplacental Transmission of SARS-CoV-2 from Infected Pregnant Mothers. Arch Pathol Lab Med 2020; 144: 1451–1456 34 Radermacher WJ. Wie Statistiken helfen können – über COVID-19 hinaus. Statistisches Bundesamt | WISTA | 4 | 2020; 23–29 PubMedGoogle Scholar 35 Everts J. The dashboard pandemic. Dialogues in Human Geography 2020; 10: 260-264 CrossrefPubMedGoogle Scholar 36 Johns Hopkins University. COVID-19 Dashboard. 2020 July 11, 2020]; Available from https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6 37 Doll R. Introduction and overview. Epidemiology of lung cancer. Lung biology and health and disease. Vol. 74 1994. Marcel Dekker, Inc; New York-Basel-Hong Kong: CrossrefGoogle Scholar 38 Allebeck P, Wallin AS. In search of the relevant covid research. Eur J Public Health. 2020 Google Scholar
{{detailinfo.data.api.data.document[0].apa}}
{{detailinfo.data.api.data.document[0].vancouver}}
{{detailinfo.data.api.data.document[0].harvard}}